Articles /research /publications

Clinical abstracts and presentations

July 2008 Abstract (Text)11th Liposome Research Days Conference Yokohama, Japan
July 2008 Abstract (Poster) 11th Liposome Research Days Yokohama, Japan
March 2008 Abstract (Text): SIR 2008 Conference: Imaging Features in Patients Undergoing Liver RFA plus Heat Deployed Nanoparticles, Washington, DC,
March 2008 Abstract (Presentation): SIR 2008 Conference: Imaging Features in Patients Undergoing Liver RFA plus Heat Deployed Nanoparticles, Washington, DC
February 2008 Abstract (Presentation) Phase I Study of ThermoDox® (Thermally Sensitive Liposomes Containing Doxorubicin Given Prior to Radiofrequency Ablation for Unresectable Liver Cancers
February 2008 Abstract (Text) Phase I Study of ThermoDox® (Thermally Sensitive Liposomes Containing Doxorubicin Given Prior to Radiofrequency Ablation for Unresectable Liver Cancers
January 2007 Abstract (Presentation): 2007 ASCO-GI Conference: Phase I study of thermally sensitive liposomes containing doxorubicin (ThermoDox) given during Radiofrequency Ablation (RFA) in patients with unresectable hepatic malignancies, Orlando, FL
January 2007 Abstract (Text): 2007 ASCO-GI Conference: Phase I study of thermally sensitive liposomes containing doxorubicin (ThermoDox) given during Radiofrequency Ablation (RFA) in patients with unresectable hepatic malignancies, Orlando, FL

Pre-Clinical abstracts and presentations

March 2007 Abstract (Presentation): SIR 2007 Conference: Pulsed-High Intensity Focused Ultrasound (HIFU) enhanced delivery and produced tumor growth inhibition when using Heat Sensitive Liposome encapsulating Doxorubicin (ThermoDox®), Seattle, WA

Journal articles and publications

August 3, 2010 Journal of Clinical Oncology: Hepatocellular Carcinoma: Consensus Recommendation of the National Cancer Institute Clinical Trials Planning Meeting
March 16, 2010 The heat is on at Celsion: Small biotech is making giant strides in heat-mediated targeted drug delivery
Aug 25, 2008 PharmAsia News: Celsion Initiates First International Licensing Deal With Japan's Yakult For Liver Cancer Drug ThermoDox
Mar 21, 2008 Medical Device Daily: Celsion Adds Punch to its ThermoDox® liver cancer therapy
May 1, 2007 Manuscript Publication: Pulsed-High Intensity Focused Ultrasound and Low Temperature - Sensitive Liposomes for Enhanced Targeted Drug Delivery and Anti-tumor Effect,
Apr 19, 2006 CBS News: Turning Up The Heat On Cancer - New Treatment Harnesses Heat To Fight Tumors
Mar 10, 2006 Oral Cancer Foundation: Turning up the heat helps shrink tumors
Mar 1, 2006 wftv.com: Heat Helps Breast Cancer Patients


Copyright © 2010 Celsion Corporation. Home  |  Privacy Policy  |  Governance  |  Media  |  Site Map